副腎がん診断の世界市場レポート 2024

副腎がん診断の市場規模は、今後数年間で大幅な成長が見込まれています。2028年には6.4%の年間複合成長率（CAGR）で1,800億9,000万米ドルに成長すると予想されます。予測期間で予想される成長は、個別化医療アプローチの採用、低侵襲処置の増加、遠隔医療と遠隔診療の統合、リキッドバイオプシー技術の開発、遺伝カウンセリングサービスの拡大によるものと考えられます。予測期間中に予想される主な動向には、診断革新に対する規制支援、デジタルパソロジーの採用、画像技術の進歩、リキッドバイオプシー開発の継続的な進歩、精密医療のためのゲノムプロファイリングの応用などが含まれます。

予想される喫煙者の増加により、副腎がん診断市場の成長が促進される見込みです。紙巻きタバコの喫煙には、精神活性効果のある中毒性アルカロイドであるニコチンを含むタバコの燃焼から出る煙を吸ったり吐き出したりすることが含まれます。腺腫や副腎皮質がんを含む副腎がんは、喫煙に関連するリスク増加と関連しています。タバコの煙に含まれる発がん物質は、副腎細胞のDNA損傷を引き起こし、その結果、がんを引き起こす可能性のある突然変異を引き起こす可能性があります。特に、カナダ統計局は、2022年7月の紙巻きタバコ生産量が2021年6月と比較して5.8%増加し、2022年6月には総販売本数が14億本に達したと報告しています。このように、紙巻きタバコの普及率の増加は、副腎がん診断市場の重要な促進力なっています。

がんを支援する政府の取り組みにより、副腎がん診断市場の成長が促進されると予想されます。これらの取り組みには、課題に対処し、診断サービスの品質とアクセシビリティを向上させ、効果的な副腎がん診断の調査を支援するために政府が講じた重要な措置が含まれます。2023年4月、バイデン・ハリス政権は、国立衛生研究所（NIH）に従って、がんに耐え、生き残った個人への支援を強化しながら、がん関連死亡を25年以内に50％削減する取り組みを確立しました。政府の取り組みは、副腎がん診断市場の成長促進に大きく貢献しています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

• 高インフレが市場に与える影響
• ウクライナ・ロシア戦争が市場に与える影響
• COVID-19による市場への影響

第5章 世界市場規模と成長

• 世界の副腎がん診断市場の促進要因と抑制要因
  • 市場の促進要因
  • 市場の抑制要因
• 世界の副腎がん診断市場規模実績と成長、2018年～2023年
• 世界の副腎がん診断市場規模と成長予測、2023年～2028年、2033年

第6章 市場セグメンテーション

• 世界の副腎がん診断市場、検査別セグメンテーション、実績と予測、2018年～2023年、2023年～2028年、2033年
• 磁気共鳴画像法（MRI）
• コンピュータ断層撮影（CT）スキャン
• X線
• 陽電子放射断層撮影法（PET）スキャン
• 生検
• 世界の副腎がん診断市場、治療別セグメンテーション、実績と予測、2018年～2023年、2023年～2028年、2033年
• 手術
• 化学療法
• 放射線療法
• がんの標的療法
• その他の治療法
• 世界の副腎がん診断市場、腫瘍の種類別セグメンテーション、実績と予測、2018年～2023年、2023年～2028年、2033年
• 褐色細胞腫
• 副腎皮質がん
• その他のタイプ
• 世界の副腎がん診断市場、エンドユーザー別セグメンテーション、実績と予測、2018年～2023年、2023年～2028年、2033年
• 病院
• 外来手術センター
• がんセンター
• その他のエンドユーザー

第7章 地域と国の分析

• 世界の副腎がん診断市場、地域別、実績と予測、2018年～2023年、2023年～2028年、2033年
• 世界の副腎がん診断市場、国別、実績と予測、2018年～2023年、2023年～2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 副腎がん診断市場の競合情勢
• 副腎がん診断市場の企業プロファイル
  • Johnson And Johnson Pvt Ltd.
  • F. Hoffmann-La Roche Ltd.
  • Thermo Fisher Scientific
  • GSK plc
  • AstraZeneca plc

第31章 その他の大手と革新的な企業

• Abbott Laboratories
• Siemens Healthcare GmbH
• Becton Dickinson and Company
• Koninklijke Philips NV
• GE HealthCare Technologies Inc.
• Agilent Technologies
• Hologic Inc.
• PerkinElmer Inc.
• Illumina Inc.
• Roche Diagnostics
• BioMerieux SA
• Sysmex Corporation
• Bio-Rad Laboratories Inc.
• Bruker Corporation
• Exact Sciences Corp.

第32章 競合ベンチマーキング

第33章 競合ダッシュボード

第34章 主要な合併と買収

第35章 将来の見通しと可能性の分析

第36章 付録

Adrenal cancer diagnostics involve the identification and detection of cancer originating in the adrenal glands, situated above the kidneys. This process encompasses a series of medical assessments, tests, and procedures designed to establish the presence of adrenal cancer, playing a crucial role in effective treatment planning and management.

The primary diagnostic tests for adrenal cancer include magnetic resonance imaging (MRI), computed tomography (CT) scans, X-rays, positron emission tomography (PET) scans, and biopsies. Magnetic resonance imaging (MRI) is a medical imaging technique that utilizes strong magnetic fields and radio waves to generate detailed and high-resolution images of the body's internal structures. Treatment modalities encompass surgery, chemotherapy, radiotherapy, targeted cancer therapies, and others tailored for pheochromocytoma, adrenal cortical carcinoma, and various tumor types. These treatments are administered by diverse end-users such as hospitals, ambulatory surgical centers, cancer centers, and others.

The adrenal cancer diagnostics market research report is one of a series of new reports from The Business Research Company that provides adrenal cancer diagnostics market statistics, including adrenal cancer diagnostics industry global market size, regional shares, competitors with an adrenal cancer diagnostics market share, detailed adrenal cancer diagnostics market segments, market trends and opportunities, and any further data you may need to thrive in the adrenal cancer diagnostics industry. This adrenal cancer diagnostics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The adrenal cancer diagnostics market size has grown strongly in recent years. It will grow from $130.84 billion in 2023 to $140.35 billion in 2024 at a compound annual growth rate (CAGR) of 7.3%. The growth observed in the historical period can be ascribed to an elevated incidence and awareness of the condition, advancements in genetic and molecular testing, improvements in biopsy techniques, enhanced endocrine testing, and the integration of artificial intelligence (AI).

The adrenal cancer diagnostics market size is expected to see strong growth in the next few years. It will grow to $180.09 billion in 2028 at a compound annual growth rate (CAGR) of 6.4%. The anticipated growth in the forecast period can be attributed to the adoption of personalized medicine approaches, an increase in minimally invasive procedures, the integration of telemedicine and remote consultations, the development of liquid biopsy techniques, and the expansion of genetic counseling services. Key trends expected in the forecast period include regulatory support for diagnostic innovations, the adoption of digital pathology, advancements in imaging technologies, ongoing progress in liquid biopsy development, and the application of genomic profiling for precision medicine.

The anticipated rise in cigarette smoking is poised to drive the growth of the adrenal cancer diagnostics market. Cigarette smoking involves inhaling and exhaling fumes from burning tobacco containing nicotine, an addictive alkaloid with psychoactive effects. Adrenal cancer, including adenomas and adrenocortical carcinomas, has been linked to increased risks associated with cigarette smoking. The carcinogens in tobacco smoke can lead to DNA damage in adrenal cells, resulting in mutations that may cause cancer. Notably, Statistics Canada reported a 5.8% increase in cigarette production in July 2022 compared to June 2021, with the total number of cigarettes sold reaching 1.4 billion in June 2022. Thus, the growing prevalence of cigarette smoking is a key driver for the adrenal cancer diagnostics market.

Government initiatives supporting cancer are expected to propel the growth of the adrenal cancer diagnostics market. These initiatives involve significant actions taken by governments to address challenges, improve diagnostic services' quality and accessibility, and support research for effective adrenal cancer diagnostics. In April 2023, the Biden-Harris administration, as per the National Institutes of Health (NIH), established an initiative to reduce cancer-related deaths by 50% within 25 years while enhancing support for individuals enduring and surviving cancer. Government initiatives contribute significantly to driving the growth of the adrenal cancer diagnostics market.

A substantial obstacle to the adrenal cancer diagnostics market is the high cost of diagnostic imaging systems. The expense associated with these systems and procedures poses challenges in terms of access to timely and accurate diagnoses, potentially leading to delayed treatment and financial burdens for patients. According to the American College of Physicians, surplus imaging costs the healthcare system between $200-$250 billion annually. Therefore, the considerable cost linked to diagnostic imaging systems represents a significant constraint for the adrenal cancer diagnostics market.

Major companies in the adrenal cancer diagnostics market are enhancing profitability by developing innovative products incorporating advanced technologies such as the High-V MRI platform and DryCool technology. The High-V MRI platform integrates digitalization with a new field strength of 0.55T, ensuring exceptional diagnostic quality for routine and new clinical applications. Meanwhile, DryCool technology is a virtually helium-free scanner utilizing a closed-loop cooling system to cool the magnet. Siemens Healthcare GmbH introduced the Magnetom Free.Star1 MRI scanner in November 2021 for adrenal cancer diagnostics. This cost-effective and user-friendly scanner, based on Siemens Healthineers' High-V MRI platform and DryCool technology, is expected to facilitate earlier and more accurate diagnoses, improving patient outcomes across various medical conditions.

In May 2021, Exact Sciences Corp., a US-based molecular diagnostics company, acquired Thrive Earlier Detection Corp. for $2.15 billion. This strategic move by Exact Sciences aims to expand its presence in the early cancer detection market, strengthen its competitive position, and accelerate the development and commercialization of THX-251. Thrive Earlier Detection Corp., a US-based biotechnology company, specializes in products related to adrenal cancer diagnostics.

Major companies operating in the adrenal cancer diagnostics market report are Johnson And Johnson Pvt Ltd., F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific, GSK plc, AstraZeneca plc, Abbott Laboratories, Siemens Healthcare GmbH, Becton Dickinson and Company, Koninklijke Philips N.V., GE HealthCare Technologies Inc., Agilent Technologies, Hologic Inc., PerkinElmer Inc., Illumina Inc., Roche Diagnostics, BioMerieux SA, Sysmex Corporation, Bio-Rad Laboratories Inc., Bruker Corporation, Exact Sciences Corp., Natera Inc., Invitae Corporation, Qiagen NV, Guardant Health Inc., Foundation Medicine Inc., NanoString Technologies Inc., TRS Technologies Inc., Morgan Advanced Materials, APC International Ltd., Annon Piezo Technology Co. Limited

North America was the largest region in the adrenal cancer diagnostics market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the adrenal cancer diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the adrenal cancer diagnostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The adrenal cancer diagnostics market consists of revenues earned by entities by providing genetic testing, histopathology, blood tests, and dexamethasone suppression tests. The market value includes the value of related goods sold by the service provider or included within the service offering. The adrenal cancer diagnostics market also includes sales of ultrasound machines, reagents and test kits, microscopes, histology kits, and microtomes. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Adrenal Cancer Diagnostics Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on adrenal cancer diagnostics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
• Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
• Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
• Measure the impact of high global inflation on market growth.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for adrenal cancer diagnostics? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The adrenal cancer diagnostics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

• 1) By Test: Magnetic Resonance Imaging (MRI); Computed Tomography (CT) Scan; X-ray; Positron Emission Tomography (PET) Scan; Biopsy
• 2) By Treatment: Surgery; Chemotherapy; Radiotherapy; Targeted Cancer Therapies; Other Treatments
• 3) By Tumor Type: Pheochromocytoma; Adrenal Cortical Carcinoma; Other Types
• 4) By End-User: Hospitals; Ambulatory Surgical Centers; Cancer Centers; Other End-Users
• Companies Mentioned: Johnson And Johnson Pvt Ltd.; F. Hoffmann-La Roche Ltd.; Thermo Fisher Scientific; GSK plc; AstraZeneca plc
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Adrenal Cancer Diagnostics Market Characteristics

3. Adrenal Cancer Diagnostics Market Trends And Strategies

4. Adrenal Cancer Diagnostics Market - Macro Economic Scenario

• 4.1. Impact Of High Inflation On The Market
• 4.2. Ukraine-Russia War Impact On The Market
• 4.3. COVID-19 Impact On The Market

5. Global Adrenal Cancer Diagnostics Market Size and Growth

• 5.1. Global Adrenal Cancer Diagnostics Market Drivers and Restraints
  • 5.1.1. Drivers Of The Market
  • 5.1.2. Restraints Of The Market
• 5.2. Global Adrenal Cancer Diagnostics Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
• 5.3. Global Adrenal Cancer Diagnostics Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Adrenal Cancer Diagnostics Market Segmentation

• 6.1. Global Adrenal Cancer Diagnostics Market, Segmentation By Test, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Magnetic Resonance Imaging (MRI)
• Computed Tomography (CT) Scan
• X-ray
• Positron Emission Tomography (PET) Scan
• Biopsy
• 6.2. Global Adrenal Cancer Diagnostics Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Surgery
• Chemotherapy
• Radiotherapy
• Targeted Cancer Therapies
• Other Treatments
• 6.3. Global Adrenal Cancer Diagnostics Market, Segmentation By Tumor Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Pheochromocytoma
• Adrenal Cortical Carcinoma
• Other Types
• 6.4. Global Adrenal Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Hospitals
• Ambulatory Surgical Centers
• Cancer Centers
• Other End-Users

7. Adrenal Cancer Diagnostics Market Regional And Country Analysis

• 7.1. Global Adrenal Cancer Diagnostics Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 7.2. Global Adrenal Cancer Diagnostics Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Adrenal Cancer Diagnostics Market

• 8.1. Asia-Pacific Adrenal Cancer Diagnostics Market Overview
• Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Adrenal Cancer Diagnostics Market, Segmentation By Test, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.3. Asia-Pacific Adrenal Cancer Diagnostics Market, Segmentation By Tumor Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.4. Asia-Pacific Adrenal Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Adrenal Cancer Diagnostics Market

• 9.1. China Adrenal Cancer Diagnostics Market Overview
• 9.2. China Adrenal Cancer Diagnostics Market, Segmentation By Test, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.3. China Adrenal Cancer Diagnostics Market, Segmentation By Tumor Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.4. China Adrenal Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Adrenal Cancer Diagnostics Market

• 10.1. India Adrenal Cancer Diagnostics Market, Segmentation By Test, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.2. India Adrenal Cancer Diagnostics Market, Segmentation By Tumor Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.3. India Adrenal Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Adrenal Cancer Diagnostics Market

• 11.1. Japan Adrenal Cancer Diagnostics Market Overview
• 11.2. Japan Adrenal Cancer Diagnostics Market, Segmentation By Test, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.3. Japan Adrenal Cancer Diagnostics Market, Segmentation By Tumor Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.4. Japan Adrenal Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Adrenal Cancer Diagnostics Market

• 12.1. Australia Adrenal Cancer Diagnostics Market, Segmentation By Test, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.2. Australia Adrenal Cancer Diagnostics Market, Segmentation By Tumor Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.3. Australia Adrenal Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Adrenal Cancer Diagnostics Market

• 13.1. Indonesia Adrenal Cancer Diagnostics Market, Segmentation By Test, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.2. Indonesia Adrenal Cancer Diagnostics Market, Segmentation By Tumor Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.3. Indonesia Adrenal Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Adrenal Cancer Diagnostics Market

• 14.1. South Korea Adrenal Cancer Diagnostics Market Overview
• 14.2. South Korea Adrenal Cancer Diagnostics Market, Segmentation By Test, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.3. South Korea Adrenal Cancer Diagnostics Market, Segmentation By Tumor Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.4. South Korea Adrenal Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Adrenal Cancer Diagnostics Market

• 15.1. Western Europe Adrenal Cancer Diagnostics Market Overview
• 15.2. Western Europe Adrenal Cancer Diagnostics Market, Segmentation By Test, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.3. Western Europe Adrenal Cancer Diagnostics Market, Segmentation By Tumor Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.4. Western Europe Adrenal Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Adrenal Cancer Diagnostics Market

• 16.1. UK Adrenal Cancer Diagnostics Market, Segmentation By Test, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.2. UK Adrenal Cancer Diagnostics Market, Segmentation By Tumor Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.3. UK Adrenal Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Adrenal Cancer Diagnostics Market

• 17.1. Germany Adrenal Cancer Diagnostics Market, Segmentation By Test, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.2. Germany Adrenal Cancer Diagnostics Market, Segmentation By Tumor Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.3. Germany Adrenal Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Adrenal Cancer Diagnostics Market

• 18.5. France Adrenal Cancer Diagnostics Market, Segmentation By Test, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.6. France Adrenal Cancer Diagnostics Market, Segmentation By Tumor Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.7. France Adrenal Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Adrenal Cancer Diagnostics Market

• 19.9. Italy Adrenal Cancer Diagnostics Market, Segmentation By Test, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.10. Italy Adrenal Cancer Diagnostics Market, Segmentation By Tumor Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.11. Italy Adrenal Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Adrenal Cancer Diagnostics Market

• 20.13. Spain Adrenal Cancer Diagnostics Market, Segmentation By Test, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.14. Spain Adrenal Cancer Diagnostics Market, Segmentation By Tumor Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.15. Spain Adrenal Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Adrenal Cancer Diagnostics Market

• 21.1. Eastern Europe Adrenal Cancer Diagnostics Market Overview
• 21.2. Eastern Europe Adrenal Cancer Diagnostics Market, Segmentation By Test, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.3. Eastern Europe Adrenal Cancer Diagnostics Market, Segmentation By Tumor Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.4. Eastern Europe Adrenal Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Adrenal Cancer Diagnostics Market

• 22.1. Russia Adrenal Cancer Diagnostics Market, Segmentation By Test, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.2. Russia Adrenal Cancer Diagnostics Market, Segmentation By Tumor Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.3. Russia Adrenal Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Adrenal Cancer Diagnostics Market

• 23.1. North America Adrenal Cancer Diagnostics Market Overview
• 23.2. North America Adrenal Cancer Diagnostics Market, Segmentation By Test, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.3. North America Adrenal Cancer Diagnostics Market, Segmentation By Tumor Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.4. North America Adrenal Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Adrenal Cancer Diagnostics Market

• 24.1. USA Adrenal Cancer Diagnostics Market Overview
• 24.2. USA Adrenal Cancer Diagnostics Market, Segmentation By Test, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.3. USA Adrenal Cancer Diagnostics Market, Segmentation By Tumor Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.4. USA Adrenal Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Adrenal Cancer Diagnostics Market

• 25.1. Canada Adrenal Cancer Diagnostics Market Overview
• 25.2. Canada Adrenal Cancer Diagnostics Market, Segmentation By Test, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.3. Canada Adrenal Cancer Diagnostics Market, Segmentation By Tumor Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.4. Canada Adrenal Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Adrenal Cancer Diagnostics Market

• 26.1. South America Adrenal Cancer Diagnostics Market Overview
• 26.2. South America Adrenal Cancer Diagnostics Market, Segmentation By Test, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.3. South America Adrenal Cancer Diagnostics Market, Segmentation By Tumor Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.4. South America Adrenal Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Adrenal Cancer Diagnostics Market

• 27.1. Brazil Adrenal Cancer Diagnostics Market, Segmentation By Test, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.2. Brazil Adrenal Cancer Diagnostics Market, Segmentation By Tumor Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.3. Brazil Adrenal Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Adrenal Cancer Diagnostics Market

• 28.1. Middle East Adrenal Cancer Diagnostics Market Overview
• 28.2. Middle East Adrenal Cancer Diagnostics Market, Segmentation By Test, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.3. Middle East Adrenal Cancer Diagnostics Market, Segmentation By Tumor Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.4. Middle East Adrenal Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Adrenal Cancer Diagnostics Market

• 29.1. Africa Adrenal Cancer Diagnostics Market Overview
• 29.2. Africa Adrenal Cancer Diagnostics Market, Segmentation By Test, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.3. Africa Adrenal Cancer Diagnostics Market, Segmentation By Tumor Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.4. Africa Adrenal Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Adrenal Cancer Diagnostics Market Competitive Landscape And Company Profiles

• 30.1. Adrenal Cancer Diagnostics Market Competitive Landscape
• 30.2. Adrenal Cancer Diagnostics Market Company Profiles
  • 30.2.1. Johnson And Johnson Pvt Ltd.
    • 30.2.1.1. Overview
    • 30.2.1.2. Products and Services
    • 30.2.1.3. Strategy
    • 30.2.1.4. Financial Performance
  • 30.2.2. F. Hoffmann-La Roche Ltd.
    • 30.2.2.1. Overview
    • 30.2.2.2. Products and Services
    • 30.2.2.3. Strategy
    • 30.2.2.4. Financial Performance
  • 30.2.3. Thermo Fisher Scientific
    • 30.2.3.1. Overview
    • 30.2.3.2. Products and Services
    • 30.2.3.3. Strategy
    • 30.2.3.4. Financial Performance
  • 30.2.4. GSK plc
    • 30.2.4.1. Overview
    • 30.2.4.2. Products and Services
    • 30.2.4.3. Strategy
    • 30.2.4.4. Financial Performance
  • 30.2.5. AstraZeneca plc
    • 30.2.5.1. Overview
    • 30.2.5.2. Products and Services
    • 30.2.5.3. Strategy
    • 30.2.5.4. Financial Performance

31. Adrenal Cancer Diagnostics Market Other Major And Innovative Companies

• 31.1. Abbott Laboratories
• 31.2. Siemens Healthcare GmbH
• 31.3. Becton Dickinson and Company
• 31.4. Koninklijke Philips N.V.
• 31.5. GE HealthCare Technologies Inc.
• 31.6. Agilent Technologies
• 31.7. Hologic Inc.
• 31.8. PerkinElmer Inc.
• 31.9. Illumina Inc.
• 31.10. Roche Diagnostics
• 31.11. BioMerieux SA
• 31.12. Sysmex Corporation
• 31.13. Bio-Rad Laboratories Inc.
• 31.14. Bruker Corporation
• 31.15. Exact Sciences Corp.

32. Global Adrenal Cancer Diagnostics Market Competitive Benchmarking

33. Global Adrenal Cancer Diagnostics Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Adrenal Cancer Diagnostics Market

35. Adrenal Cancer Diagnostics Market Future Outlook and Potential Analysis

• 35.1 Adrenal Cancer Diagnostics Market In 2028 - Countries Offering Most New Opportunities
• 35.2 Adrenal Cancer Diagnostics Market In 2028 - Segments Offering Most New Opportunities
• 35.3 Adrenal Cancer Diagnostics Market In 2028 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer